Who Owns Ardelyx Stock?
NASDAQ: ARDXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 12:07 PM ET
Ownership breakdown
- Held by institutions
- 73.23%
- Held by insiders
- 3.04%
- Institutional holders
- 328
- Institutions 73.2%
- Insiders 3.0%
- Public and other 23.7%
Who owns Ardelyx stock?
Institutional investors own about 73.2% of Ardelyx's shares, spread across 328 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 3.04% of ARDX.
The largest institutional holders are Blackrock Inc. (9.43%), Rubric Capital Management LP (6.50%) and Millennium Management Llc (5.58%). Together, the top 10 institutions control 44.9% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their ARDX positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ARDX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 23.50M | 9.43% | +11.1% |
| Rubric Capital Management LP | 16.20M | 6.50% | +770.7% |
| Millennium Management Llc | 13.90M | 5.58% | -22.1% |
| State Street Corporation | 13.36M | 5.36% | -1.8% |
| Vanguard Capital Management LLC | 10.47M | 4.20% | +1.0% |
| Nomura Asset Management International Inc | 9.55M | 3.83% | +16.9% |
| Vanguard Portfolio Management LLC | 8.03M | 3.22% | +20.5% |
| Geode Capital Management, LLC | 6.40M | 2.57% | +6.6% |
| Jupiter Topco LLC | 5.30M | 2.13% | +100.0% |
| Two Sigma Investments, LP | 5.21M | 2.09% | +21.9% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ARDX
| Fund | Shares | % Held |
|---|---|---|
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 7.83M | 3.14% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 7.40M | 2.97% |
| iShares Trust-iShares Russell 2000 ETF | 6.27M | 2.51% |
| Delaware Group Equity Funds V-Nomura Small Cap Core Fund | 6.27M | 2.51% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 2.83M | 1.14% |
| VANGUARD HORIZON FUNDS-Vanguard Strategic Equity Fund | 2.70M | 1.08% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 2.67M | 1.07% |
| iShares Trust-iShares Russell 2000 Growth ETF | 2.31M | 0.93% |
| JANUS INVESTMENT FUND-Janus Henderson Global Life Sciences Fund | 2.17M | 0.87% |
| Invesco Exchange-Traded Fund Trust-Invesco Biotechnology & Genome ETF | 1.73M | 0.70% |
Frequently asked questions
Who is the largest shareholder of Ardelyx?
Blackrock Inc. is the largest institutional shareholder of ARDX, owning 9.43% of shares outstanding (23.50M shares) as of its latest 13F filing.
What percentage of Ardelyx is owned by institutions?
Institutions own about 73.2% of ARDX shares and 75.5% of the public float.
How much of Ardelyx do insiders own?
Insiders, such as officers and directors, own about 3.04% of ARDX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.